Switzerland

BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound... 2008-03-25

BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound... 2008-03-25

Switzerland's medical device market is highly developed and was worth approximately US$4.1bn in 2007. By 2012 the market should reach a value of US$5.2bn, representing a compound... 2008-03-13

Swiss drugmaker Roche has expanded its Technology Transfer Initiative for the production of generic versions of the company's patented second line antiretroviral (ARV) Invirase (saquinavir)... 2008-01-17

In response to the tough operating environment currently being experienced by multinational pharmaceutical companies, Swiss giant

The US FDA has approved Swiss drugmaker

Swiss drug giant Novartis has announced that it is to invest US$700mn in a new biotechnology manufacturing plant in Singapore.

Swiss pharmaceutical producer and wholesaler

Novartis - formed in 1996 through the merger of two Swiss drug firms Sandoz and Ceiba-Geigy - is the largest drugmaker in Switzerland, leading rival Roche by around US$5bn in annual... 2007-07-20

US biotech firm Northwest Biotherapeutics has had its experimental brain cancer vaccine DCVax-Brain approved in Switzerland, making it the first country to register the new drug.... 2007-07-12